HRT and Skin: What Hormone Replacement Therapy Does for Your Skin (And What It Doesn't)
Hormone replacement therapy (HRT) is increasingly in the conversation about menopausal health — and for good reason. As evidence has accumulated and risk profiles have been reassessed, more women and their healthcare providers are revisiting HRT as a legitimate option for managing the systemic effects of estrogen decline.
Skin is one of those effects. And HRT does have real, measurable benefits for menopausal skin. But understanding what it does, what it doesn't do, and how it interacts with topical prescription skincare helps clarify what a complete approach looks like.
What happens to skin during menopause
Estrogen plays a foundational role in skin structure — stimulating collagen synthesis, maintaining skin thickness, supporting hydration and barrier function, and regulating wound healing. When estrogen declines through perimenopause and menopause, the downstream effects on skin are significant and specific.
Studies show skin loses approximately 30% of its collagen in the first five years after menopause — disproportionately faster than aging alone. Skin becomes measurably thinner, drier, less elastic, and slower to repair. These are structural changes, not just surface-level dryness.
Read more about perimenopause skin changes and the biological mechanisms behind them.
What HRT does for skin — the evidence
Systemic HRT has genuine, documented benefits for skin collagen and structure. Studies show:
Collagen preservation. Women on HRT lose collagen more slowly than those not on HRT. Some studies show partial reversal of existing collagen loss with long-term HRT use.
Improved skin thickness. Dermal thickness — which declines significantly in early menopause — is measurably better preserved in women using systemic estrogen.
Better hydration and barrier function. Estrogen influences hyaluronic acid production and barrier lipid composition. HRT improves skin hydration objectively measured in clinical studies.
Reduced skin wrinkling. Some studies show reduced fine line severity in HRT users compared to non-users at equivalent ages.
These benefits are real. HRT is not just a marketing claim for skin — the mechanism is well understood and the evidence base is solid.
What HRT doesn't fully address
Systemic HRT delivers estrogen throughout the body. This is beneficial for many menopausal symptoms, including the skin changes described above. But it has limitations for skin specifically:
It doesn't replace a prescription retinoid. HRT supports collagen through the hormonal pathway — estrogen receptor stimulation in fibroblasts. Tretinoin stimulates collagen through a completely different pathway — retinoic acid receptor binding in fibroblasts. These mechanisms are additive. Women using both HRT and prescription retinoids get collagen support from two independent biological pathways simultaneously.
It doesn't address pigmentation. Hormonal fluctuations can trigger melasma and hyperpigmentation. HRT doesn't meaningfully address existing pigmentation — targeted prescription actives are needed for that. The Pigment Modulation add-on addresses melasma and post-inflammatory hyperpigmentation through tranexamic acid, azelaic acid, and kojic acid.
It doesn't deliver localised treatment. Systemic HRT distributes hormones throughout the body. For patients who want hormonal skin support specifically, topical estriol — applied directly to the skin — provides localised treatment without systemic exposure. Read more about this through the Hormone-Informed Support formula.
HRT and skin: combined with prescription retinoids
The combination of HRT (or topical estriol) with prescription tretinoin is increasingly recognised as the most comprehensive approach to menopausal skin health for patients where both are appropriate.
The reasoning is mechanistic: estrogen support and retinoid action stimulate collagen through different cellular pathways. Using both is not redundant — it's additive. Studies of combined estrogen and tretinoin use show greater improvement in skin thickness and collagen density than either alone.
The Core Formula provides the retinoid foundation — prescription tretinoin for collagen synthesis, cell turnover, and long-term structural support. The Hormone-Informed Support formula adds topical estriol for patients where direct hormonal skin support is appropriate. Read more about how collagen loss and menopause are connected and the clinical case for addressing both mechanisms.
Is HRT right for you?
This is a conversation to have with your primary care provider or a menopause specialist. The risk-benefit calculation for systemic HRT depends on your individual health history — cardiovascular status, family history, breast cancer history, timing of menopause relative to when HRT is started, and other factors.
What's changed in recent years is that the evidence has become more nuanced. The early concerns from the Women's Health Initiative study (published 2002) led to widespread HRT avoidance for nearly two decades. More recent analysis suggests the risks were overstated for many women, particularly those starting HRT early in the menopausal transition.
If you're considering HRT for skin or other menopausal symptoms, a conversation with a healthcare provider informed by current evidence is the right starting point. Laevo's clinical assessment includes a review of hormonal history and can discuss whether topical estriol is appropriate for your situation — but systemic HRT decisions require a primary care or menopause medicine consultation.
Getting topical prescription support for menopausal skin
Whether or not systemic HRT is part of your healthcare plan, topical prescription treatment is available through Laevo for the skin manifestations of estrogen decline.
The Laevo assessment covers your hormonal stage, skin history, current medications (including any existing HRT), and specific concerns. Your clinician designs your formula based on the full clinical picture.
Assessment fee applies. Prescription required — not all applicants will be approved. Topical estriol is a prescription hormone — health history review is conducted before prescribing. Individual results vary. This article is for informational purposes only and does not constitute medical advice. Systemic HRT decisions should be made with your primary healthcare provider. Consult your healthcare provider before starting any prescription treatment.
